Feds fine St. Louis drug maker $3.5 million
(AP)—A St. Louis-based drug maker is paying $3.5 million to settle a federal lawsuit that it illegally paid doctors to prescribe out-of-date antidepressants and sleep aids to Medicare and Medicaid patients.
Learned helplessness in flies and the roots of depression
When faced with impossible circumstances beyond their control, animals, including humans, often hunker down as they develop sleep or eating disorders, ulcers, and other physical manifestations of depression. ...
Drugmakers brace for generic versions of biotech blockbusters
In 2001, Abbott Laboratories spent nearly $7 billion on the biggest acquisition in the company's 123-year history, primarily to access one drug, Humira.
Sickness certification challenges the physician
Difficulties in assessing the patients work capacity, non-medical problems, and handling situations in which the patients have different opinions about the need for sick leave are some of the challenges that physicians meet ...
Antidepressants linked to thicker arteries
Antidepressant use has been linked to thicker arteries, possibly contributing to the risk of heart disease and stroke, in a study of twin veterans. The data is being presented Tuesday, April 5 at the American College of Cardiology ...
Culture, stigma affect mental health care for Latinos
Latinos benefit from antidepressants like everybody else only they do not use them nearly as often. The trick is getting past some cultural barriers.
Online messaging delivers follow-up care for depression
Online messaging can deliver organized follow-up care for depression effectively and efficiently, according to a randomized controlled trial of 208 Group Health patients that the Journal of General Internal Medicine e-published in adv ...
New model for probing antidepressant actions
medicines such as Prozac, Lexapro and Paxil work by blocking the serotonin transporter, a brain protein that normally clears away the mood-regulating chemical serotonin. Or so the current thinking goes.
A second pathway for antidepressants: New fluorescent assay reveals TREK1 mechanism
(PhysOrg.com) -- Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) ...
Integrative Medicine: Cognitive behavioral therapy
We know that the state of the mind has a lot to do with how healthy the body is. An interesting study published this month in the Annals of Internal Medicine demonstrates the mind-body connection yet again - this time ...
FDA declines to approve Orexigen diet drug
(AP) -- Orexigen Therapeutics Inc. shares plunged nearly 75 percent in pre-market trading Tuesday after U.S. health officials declined to approve the experimental weight loss pill Contrave.
Restoring emotional memory in a rat model of major depressive disorder
Deficits in emotional memory processing associated with major depressive disorder (MDD) are shown to be reversible by distinct antidepressants, shows researchers at Karolinska Institutet in an animal study.
Light therapy promising for treating major depression
As Americans keep getting fatter, doctors ask: Where are the drugs?
In their quest to find drugs to curb obesity, scientists have had about as much success as long-term dieters who want to stay thin - which is to say, very little. In fact, the last year has been so bleak on the research front ...